123 related articles for article (PubMed ID: 7151088)
21. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
[TBL] [Abstract][Full Text] [Related]
22. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship.
Murakami R; Sano K; Murakami Y; Shimada T; Morioka S
Int J Cardiol; 1995 Aug; 51(1):57-63. PubMed ID: 8522398
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.
Legrand V; Vandormael M; Collignon P; Kulbertus HE
Am J Cardiol; 1983 Feb; 51(3):422-6. PubMed ID: 6823856
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.
Silke B; Graham DJ; Verma SP; Reynolds G; Frais MA; Finlayson JR; Taylor SH
Eur J Clin Pharmacol; 1986; 29(6):651-7. PubMed ID: 3709609
[TBL] [Abstract][Full Text] [Related]
25. Negative inotropic effect of intravenous nifedipine in coronary artery disease: relation to plasma levels.
Clifton GD; Booth DC; Hobbs S; Boucher BA; Foster TS; McAllister RG; DeMaria AN
Am Heart J; 1990 Feb; 119(2 Pt 1):283-90. PubMed ID: 2301217
[TBL] [Abstract][Full Text] [Related]
26. Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
Silke B; Verma SP; Zezulka AV; Sharma S; Reynolds G; Jackson NC; Guy S; Taylor SH
Br J Clin Pharmacol; 1990 Apr; 29(4):437-45. PubMed ID: 2139339
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic assessment of intravenous bepridil administration in ischemic heart disease.
Tamari I; Borer JS; Moses JW; Goldberg HL; Fisher J; Wallis JB; Halle A
Am J Cardiol; 1985 Mar; 55(7):25C-29C. PubMed ID: 3872054
[TBL] [Abstract][Full Text] [Related]
28. Acute haemodynamic effects of cromakalim in patients with angina pectoris.
Thomas P; Dixon MS; Winterton SJ; Sheridan DJ
Br J Clin Pharmacol; 1990 Mar; 29(3):325-31. PubMed ID: 2310656
[TBL] [Abstract][Full Text] [Related]
29. Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans.
Bartels GL; Remme WJ; Pillay M; Schönfeld DH; Cox PH; Kruijssen HA; Knufman NM
J Cardiovasc Pharmacol; 1992 Jul; 20(1):157-64. PubMed ID: 1383625
[TBL] [Abstract][Full Text] [Related]
30. The hemodynamic effects of intravenous tocainide in patients with heart disease.
Winkle RA; Anderson JL; Peters F; Meffin PJ; Fowles RE; Harrison DC
Circulation; 1978 Apr; 57(4):787-92. PubMed ID: 630689
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of a new calcium antagonist, SR 33557, in patients with coronary artery disease and normal left ventricular function.
Saal JP; Lellouche D; Habbal R; Sissmann J; Castaigne A; Dubois-Randé JL
J Cardiovasc Pharmacol; 1994 Jan; 23(1):87-91. PubMed ID: 7511741
[TBL] [Abstract][Full Text] [Related]
32. Acute hemodynamic effects of intravenous nicardipine in patients treated chronically with propranolol for coronary artery disease.
Rocha P; Zannier D; Baron B; Pathe M; David D; Kahn JC
Am J Cardiol; 1987 Apr; 59(8):775-81. PubMed ID: 3825937
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
Gerold M; Eigenmann R; Haeusler G
J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic dose-response effects of flecainide in acute myocardial infarction with and without left ventricular decompensation.
Jackson N; Verma SP; Frais MA; Silke B; Hafizullah M; Reynolds G; Taylor SH
Clin Pharmacol Ther; 1985 Jun; 37(6):619-24. PubMed ID: 3891187
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function.
Alpert JS; Benotti JR; Brady PM; McCue JE; Weiner BH; Ockene IS
Am J Cardiol; 1985 Mar; 55(7):20C-24C. PubMed ID: 3872053
[TBL] [Abstract][Full Text] [Related]
36. Effects of verapamil on myocardial performance in coronary disease.
Ferlinz J; Easthope JL; Aronow WS
Circulation; 1979 Feb; 59(2):313-9. PubMed ID: 365390
[TBL] [Abstract][Full Text] [Related]
37. Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials.
Singh BN; Jewitt DE; Downey JM; Kirk ES; Sonnenblick EH
Clin Exp Pharmacol Physiol; 1976; 3(5):427-42. PubMed ID: 975630
[TBL] [Abstract][Full Text] [Related]
38. Systemic, left ventricular and coronary hemodynamic effects of intravenous diltiazem in coronary artery disease.
Joyal M; Cremer KF; Pieper JA; Feldman RL; Pepine CJ
Am J Cardiol; 1985 Sep; 56(7):413-7. PubMed ID: 4036821
[TBL] [Abstract][Full Text] [Related]
39. Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris.
Ikram H; Low CJ; Shirlaw T; Webb CM; Richards AM; Crozier IG
Am J Cardiol; 1990 Jul; 66(2):164-7. PubMed ID: 2196774
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
